Bernd Holthaus

About

Bernd Holthaus is a prominent figure in gynecologic oncology, with a focused expertise in minimally invasive surgical approaches to cervical cancer. His work is deeply intertwined with the German Society for Gynecology and Obstetrics (DGGG) and its specialized study groups, particularly the Study Group for Gynecologic Oncology (AGO) and the Study Group for Gynecologic Endoscopy (AGE). Holthaus made a significant contribution to the field by co-authoring a critical commentary on the landmark LACC trial, which compared laparoscopic versus open surgery for early-stage cervical cancer. This commentary, published in 2018 and cited 17 times, helped shape the ensuing global debate on surgical standards. Beyond this pivotal work, he actively contributes to the advancement of gynecological endoscopy, as evidenced by his congress reports for the AGE annual meeting. While his citation counts reflect a focused, high-impact niche rather than broad volume, his influence is substantial within German-speaking gynecologic oncology, where he is recognized for fostering cooperative research and challenging established surgical paradigms to improve patient outcomes.

Research Focus

Key Achievements

Top Papers

1. 1
   Comment on the LACC Trial Investigating Early-stage Cervical Cancer by the Uterus Commission of the Study Group for Gynecologic Oncology (AGO) and the Study Group for Gynecologic Endoscopy (AGE) of the German Society for Gynecology and Obstetrics (DGGG)

   17 citations · 2018
2. 2
   Congress report of the 23rd AGE annual meeting from 26th - 28th April 2018 in Hamburg

   4 citations · 2018

Key Collaborators

Contact & Links